Prevail Therapeutics

Focus: Prevail Therapeutics is a New York-based biotechnology company specializing in AAV-based gene therapies for rare and neurological diseases. The company operates as a pre-revenue biotech with a focused pipeline and modest scale.

Gene Therapy

Profile data last refreshed Yesterday · AI intelligence enriched 2mo ago

Open Jobs

14+14 this month

Growing — net +14 jobs in 30d

14 jobs added vs 0 removed. Steady team buildout.

Should You Work at Prevail Therapeutics?

AI assessment

Best suited for career builders willing to trade near-term stability for significant upside in a gene therapy-focused organization.

Why Work Here

Pioneering AAV gene therapy platform targeting high-unmet-need indications with significant commercial potential
Early-stage company offering equity upside and hands-on involvement in clinical development and commercialization

Data completeness

2/9 — Limited

Company HealthSolid

Pipeline

Early-stage

50 total

LOE Risk

Protected

No near-term cliffs

Hiring

Stable

Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.

Pipeline & Clinical Trials

A Virtual Prospective Study Exploring Activity Trackers and COVID-19 Infections

Covid19

N/A

Clinical Trials (1)

NCT04623138A Virtual Prospective Study Exploring Activity Trackers and COVID-19 Infections

N/A

Help build intelligence for Prevail Therapeutics

No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.

Share Interview Share Compensation

Data Sources

Drug label: DailyMed / FDA
Clinical trials: ClinicalTrials.gov
Patent data: FDA Orange Book
Spending data: CMS Medicare

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.

Located in New York with access to top academic medical centers and funding networks

Watch Out For

Pre-revenue status creates financial uncertainty and runway risk typical of early-stage biotech
No marketed products limits near-term revenue visibility and job security relative to established peers

Generated by Claude from Prevail Therapeutics's SEC filings, pipeline programs, hiring velocity, FDA actions, and WARN data. Inference, not editorial — verify before quoting.

Any platinum-based doublet chemotherapy

Non Small Cell Lung Cancer

N/A

Clinical Trials (1)

NCT01067794Chemotherapy in Treating Patients With Lung Cancer

N/A

Bamlanivimab

COVID-19

N/A

Clinical Trials (1)

NCT04603651Expanded Access Program to Provide Bamlanivimab (LY3819253) for the Treatment of COVID-19

N/A

iNUDGE

Non Small Cell Lung Cancer Metastatic

N/A

Clinical Trials (1)

NCT05853887Liquid Biopsy Based NGS in Newly Diagnosed NSCLC

N/A

Expert Review

Solid Tumor Malignancies

N/A

Clinical Trials (1)

NCT06896162PROGRESS: Precision Oncology Using Genomic Reflexive Evaluations for Study Selection and Survival

N/A

Donanemab

Alzheimer Disease

N/A

Clinical Trials (1)

NCT06566170A Real-World Comparative Study of Donanemab (LY3002813) Plus Usual Care Versus Usual Care Alone in US Participants With Early Symptomatic Alzheimer's Disease

N/A

florbetapir F 18 PET scan

Alzheimer Disease

N/A

Clinical Trials (1)

NCT02918539Registry of Amyloid Positive Patients for Alzheimer's Disease Drug Research Trials

N/A

Flutemetamol F18 Injection

Alzheimer Disease

N/A

Clinical Trials (1)

NCT05457998BioFINDER-Brown: Examination of Alzheimer's Disease Biomarkers

N/A

International Study on COVID-19 Vaccine to Assess Immunogenicity, Reactogenicity and Efficacy (InVIT

COVID-19

N/A

Clinical Trials (1)

NCT05096091International Study on COVID-19 Vaccine to Assess Immunogenicity, Reactogenicity and Efficacy (InVITE)

N/A

exenatide

Diabetes Mellitus

N/A

Clinical Trials (1)

NCT01281228The Effect of GLP-1 Receptor Activation on Central Reward and Satiety in Obesity and Diabetes

N/A

Implementation pRogram to Improve Screening and Management for CKD in Diabetes (IRIS-CKD) (Program 2

Chronic Kidney Disease(CKD)

N/A

Clinical Trials (1)

NCT06906640Implementation pRogram to Improve Screening and Management for CKD in Diabetes (IRIS-CKD) (Program 2)

N/A

Outpatient Characterization of the Variability of Insulin Secretory Parameters in the Meal Tolerance

Type 2 Diabetes

N/A

Diabetes Pueblo

Type2 Diabetes

N/A

Clinical Trials (1)

NCT04016584Diabetes Pueblo Program - Application and Acceptability of Culturally Appropriate Latino Education for Insulin Therapy

N/A

Characterization of the Variability of Insulin Secretory Parameters in the Meal Tolerance and the Ma

Type 2 Diabetes

N/A

Spanish Registry of Systemic Treatments in Psoriasis

Psoriasis

N/A

Duloxetine

Diabetes

N/A

Clinical Trials (1)

NCT01363284Pretreatment Identification of Duloxetine Success in Neuropathic Pain Patients

N/A

Procedure / Percutaneous angioplasty

Diabetes Mellitus

N/A

Clinical Trials (1)

NCT00489242Prediction of CK-MB Release During Otherwise Successful Stenting Procedure

N/A

Turner Syndrome Prenatal Diagnosis Study

Turner Syndrome

N/A

Clinical Trials (1)

NCT01668251Turner Syndrome Prenatal Diagnosis Study

N/A

exenatide injection

Diabetes Mellitus, Type 2

N/A

Clinical Trials (1)

NCT01147627Effect of Different Interventions on Glycemic Control and β-cell Function in Newly Diagnosed Type 2 Diabetic Patients

N/A

limited lymphadenectomy

Bladder Cancer

N/A

Clinical Trials (1)

NCT01215071Eingeschränkte vs Ausgedehnte Lymphadenektomie LEA

N/A

Diabetes Self-Management Education

Diabetes

N/A

Clinical Trials (1)

NCT00822471Feasibility and Impact of "ABCs of Diabetes" Self-Management Education Program at an Urban Public Library

N/A

No treatment given

Diabetes

N/A

Clinical Trials (1)

NCT01511393An Active Surveillance Program for Cases of Medullary Thyroid Carcinoma (MTC)

N/A

olanzapine and melatonin

Schizophrenia

N/A

Clinical Trials (1)

NCT00512070Melatonin Metabolism Abnormality in Patients With Schizophrenia or Schizoaffective Disorder Treated With Olanzapine

N/A

Dietary Intake and Nutrient Status of Children With ADHD

Attention Deficit Hyperactivity Disorder

N/A

Clinical Trials (1)

NCT00434928Dietary Intake and Nutrient Status of Children With ADHD

N/A

Epidemiological intervention

Diabetes Mellitus

N/A

Clinical Trials (1)

NCT01117831An Analysis of Diabetes Control in Puerto Rico

N/A

Celecoxib

Healthy

N/A

Clinical Trials (1)

NCT02413203Lipidomics Screening of Celecoxib in ex Vivo Human Whole Blood Assay - Part B

N/A

Characterization of the Variability of Insulin Secretory Parameters in the Meal Tolerance and the Ma

Type 2 Diabetes

N/A

Tadalafil

Raynaud

N/A

Clinical Trials (1)

NCT00822354Tadalafil for the Treatment of Raynaud's

N/A

AID System

Type 1 Diabetes Mellitus

N/A

Clinical Trials (1)

NCT03890003A Study of an Automated Insulin Delivery System in Adult Participants With Type 1 Diabetes

N/A

Exenatide

Type 2 Diabetes

N/A

Clinical Trials (1)

NCT01364584Impact of Exenatide on Cardiovascular Exercise Performance in Type 2 Diabetes

N/A

Insulins

Diabetes Mellitus, Type 2

N/A

Clinical Trials (1)

NCT01055808Observational Study in Japanese Type 2 Diabetes Patients

N/A

Jardiance

Diabetes Mellitus, Type 2

N/A

Clinical Trials (1)

NCT02489942Long Term Daily Use of JARDIANCE® Tablets in Japanese Patients With Type 2 Diabetes Mellitus

N/A

teriparatide

Osteoporosis

N/A

Clinical Trials (1)

NCT00761332Back Pain in Patients With Severe Osteoporosis

N/A

Linagliptin

Diabetes Mellitus, Type 2

N/A

Clinical Trials (1)

NCT03338803Real World Glycemic Effectiveness of Linagliptin

N/A

The Effect of Duloxetine on Interoceptive Awareness

Depressive Disorder

N/A

Clinical Trials (1)

NCT00337012The Effect of Duloxetine on Interoceptive Awareness

N/A

Olanzapine during first intervention period and placebo during second intervention period

Migraine

N/A

Clinical Trials (1)

NCT00203307A Research Study Examining the Use of Olanzapine for the Prevention of Migraine

N/A

Retinal scan

Cognitive Dysfunction

N/A

Clinical Trials (1)

NCT07254234A Study of Retinal Imaging to Detect Abnormal Protein Deposits Associated With Alzheimer's Disease

N/A

Teriparatide

Osteoporosis, Postmenopausal

N/A

Clinical Trials (1)

NCT00696644A Study for Teriparatide in Severe Osteoporosis

N/A

Didactic Session

Metastatic Gastric Cancer

N/A

Clinical Trials (1)

NCT04618809Improving the Approach to and Management of the Older Patient With Metastatic Gastric Cancer

N/A

Duloxetine

Breast Cancer

N/A

Clinical Trials (1)

NCT01028352Study to Assess Effect of 8 Wks of Duloxetine Therapy on Breast Cancer Patients With Aromatase-Inhibitor Associated Pain

N/A

Molecular tumor board assisted care

Non-Small Cell Lung Cancer

N/A

Clinical Trials (1)

NCT05254795Precision Medicine Randomized Clinical Trial Comparing Molecular Tumor Board Assisted Care to Usual Care

N/A

tadalafil

Pulmonary Arterial Hypertension

N/A

Clinical Trials (1)

NCT01066845Post Marketing Observational Study in Patients With Pulmonary Arterial Hypertension

N/A

Implementing Patients´ Competence in Oral Breast Cancer Therapy

Metastatic Breast Cancer

N/A

Clinical Trials (1)

NCT04030728Implementing Patients´ Competence in Oral Breast Cancer Therapy

N/A

Glimepiride

Type 2 Diabetes

N/A

duloxetine

Pregnancy

N/A

Clinical Trials (1)

NCT01074151The Cymbalta Pregnancy Registry

N/A

rTMS Treatment

Depression

N/A

Clinical Trials (1)

NCT00587639An Evaluation of Safety and Feasibility Using Repetitive Transcranial Magnetic Stimulation (rTMS) in Adolescents With Depression

N/A

Tirzepatide

Metabolic Health

N/A

Clinical Trials (1)

NCT06354101The Purpose of This Registry Study is to Learn More About Metabolic Health: Approximately 15,000 Participants Who Are Overweight or Have Obesity With or Without Metabolic Diseases Are Expected to Participate in This Registry Study.

N/A

weight management program

Schizophrenia

N/A

Clinical Trials (1)

NCT00169702The Effect of a Weight Management Program During Treatment With Olanzapine

N/A

Behavioral and Pharmacological Treatments

Obesity

N/A

Clinical Trials (1)

NCT07472608Obesity Medicine Bank of the Quebec Heart and Lung Institute - Laval University (IUCPQ-ULaval)